Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Getinge AB

Capitalization 52.68B 5.73B 4.94B 4.46B 4.28B 7.77B 528B 8.13B 21.12B 252B 21.5B 21.04B 906B P/E ratio 2025
26.4x
P/E ratio 2026 * 17.9x
Enterprise value 61.56B 6.69B 5.77B 5.21B 5B 9.08B 617B 9.5B 24.69B 295B 25.13B 24.59B 1,059B EV / Sales 2025
1.7x
EV / Sales 2026 * 1.7x
Free-Float
79.05%
Yield 2025 *
2.54%
Yield 2026 * 2.54%
1 day+1.95%
1 week+1.15%
Current month-2.71%
1 month-4.36%
3 months-4.41%
6 months-6.31%
Current year-9.78%
1 week 190.7
Extreme 190.7
200.7
1 month 190.7
Extreme 190.7
206
Current year 190.7
Extreme 190.7
227.8
1 year 177.25
Extreme 177.25
231.6
3 years 164.35
Extreme 164.35
275.2
5 years 164.35
Extreme 164.35
431.6
10 years 74.74
Extreme 74.74
431.6
Manager TitleAgeSince
Chief Executive Officer 54 30/04/2017
Director of Finance/CFO - 30/03/2024
Compliance Officer 47 30/09/2020
Director TitleAgeSince
Chairman 65 22/04/2019
Chairman 75 -
Director/Board Member 70 31/12/2006
Change 5d. change 1-year change 3-years change Capi.($)
+2.04%+1.15%-8.14%-9.66% 5.73B
+0.29%-0.79%+23.59%+36.02% 13.33B
+0.02%+0.03%+0.53%+0.69% 9.16B
+2.05%-2.06%+32.45%+37.31% 5.31B
-1.44%-4.19%-1.41%+11.80% 5.26B
-2.65%0.00% - - 5.05B
-1.69%-4.87%-10.80%+39.23% 4.64B
+4.98%+3.82%+11.15%-50.46% 1.78B
-1.00%-4.51%-36.03%-81.74% 1.47B
+1.34%+3.85%+32.36%-1.20% 1.39B
Average +0.39%-1.17%+4.86%-2.00% 5.31B
Weighted average by Cap. +0.12%-1.35%+8.31%+13.76%

Financials

2025 2026 *
Net sales 35.38B 3.85B 3.32B 3B 2.87B 5.22B 354B 5.46B 14.19B 170B 14.44B 14.13B 608B 35.53B 3.86B 3.33B 3.01B 2.88B 5.24B 356B 5.48B 14.25B 170B 14.5B 14.19B 611B
Net income 2.51B 273M 236M 213M 204M 371M 25.17B 388M 1.01B 12.04B 1.03B 1B 43.21B 2.88B 313M 270M 244M 233M 424M 28.81B 444M 1.15B 13.78B 1.17B 1.15B 49.45B
Net Debt 8.88B 966M 833M 752M 721M 1.31B 88.98B 1.37B 3.56B 42.56B 3.63B 3.55B 153B 7.62B 828M 715M 645M 618M 1.12B 76.31B 1.18B 3.05B 36.5B 3.11B 3.04B 131B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,670
Date Price Change Volume
10/03/26 197.40 kr +2.07% 110,033
09/03/26 193.40 kr -1.23% 422,669
06/03/26 195.80 kr -0.38% 347,544
05/03/26 196.55 kr -1.43% 374,900
04/03/26 199.40 kr +2.18% 660,237
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
193.40SEK
Average target price
228.11SEK
Spread / Average Target
+17.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GETI B Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW